Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
Akihiro Ohmoto(Japanese Foundation For Cancer Research), Shunji Takahashi(Japanese Foundation For Cancer Research)
Cited by 40
Related Papers
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
|Journal of Clinical Oncology|2023|100
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study
|Cancer Science|2021|72
Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
|Bone Marrow Transplantation|2022|18